Aptevo Therapeutics (AP81.F) Q3 2025 Earnings

11AugConfirmed
Q2 2025
Q3 2025
-78.46
-54.71
-30.97
-7.23

Details

Expected EPS
-71.627712
Actual EPS
-7.231644
Surprise EPS
64.4
Surprise Percent
+89.9%

Description

Aptevo Therapeutics (AP81.F) has reported earnings of -7.231644 per share for Q3 2025.

0 Comments

Share your thoughts